Bristol Myers to build first cell therapy factory in Europe
Teva CEO Schultz sees a 35% raise despite company's legal woes
Drug spending climbing during pandemic
Why Biogen Q1 earnings weren't good enough
*please scroll down for all the latest news*
Stay updated with the latest pharma-related coronavirus news on our new page
Today's most popular searches:
Teva CEO Schultz sees a 35% raise despite company's legal woes
Drug spending climbing during pandemic
Why Biogen Q1 earnings weren't good enough
*please scroll down for all the latest news*
Stay updated with the latest pharma-related coronavirus news on our new page
Today's most popular searches: